LAB CLOUD is established
to shape a healthier future for all.

We are committed to building a dynamic ecosystem
where innovative ideas transform into life-saving therapies.

Open innovation &
accelerating program

Leverage the power of open innovation through our bio-accelerating consortium and programs.

Elevate your R&D and business growth on our open innovation platform featuring strategic partnerships
with government entities, research institutes, and associations.

Provide optimal research environment & services focused on new drug development

Require incubation Start-up

Need animal testing Bio Venture

Desire open innovation Pharma·Bio

Bio-specific incubation

operation of accelerating Program
Semina, technology excange open innovation program
One to One consulting of business management, investment patent and more

AboutLab Cloud

LAB CLOUD is a collaborative R&D center, dedicated to incubating and accelerating bio/healthcare startups. Offering fully-equipped research infrastructure and comprehensive programs, LAB CLOUD is dedicated to meeting the diverse needs from early drug discovery to the successful commercialization.
106.7B KRW
LAB CLOUD Members' Investment Attraction
21.4B KRW
LAB CLOUD Investment Performance with 10 Cases of direct/indirect investments
112
LAB CLOUD consortium partner companies
20
LAB CLOUD bio-startup members
More view

major facilities

WOOJUNGBIO CLUSTER For New Drug Development 593-8, Dongtan Giheung-ro, Hwaseong, Gyeonggi-do,Korea

Go Link
Search Close